Availability and prices of medications used during COVID-19 pandemic

Albaroodi, Khansaa A. Ibrahim

Objectives:

The present COVID-19 pandemic has impacted all of us, but the pandemics impact and repercussions are perceived differently by individuals and governments. Locking down had an impact on pharmaceutical manufacturing, supply, and distribution, causing a medicine shortage. This study aimed to assess drugs used frequently during the pandemic in Iraq their availability and prices and determine how medications are affordable for patients. Study

design:

This was a pilot study.

Methods:

This study enrolled 30 pharmacies from rural and urban areas located in Babil governorate, Iraq; from 1 January until 1 March 2021.

Results:

According to the results, there was a difference between expensive and inexpensive medicines. Medication availability shows that many COVID-19 used medications had no local production like ipratropium, budesonide, Enoxaparin, remdesivir, and others. Levofloxacin vial 500 mg, cost more than 9000 Iraqi dinars, which is more than one day of Iraqi wage (1 day of salary = 8333 Iraqi Dinar; levofloxacin is normally given for seven days, so the total cost will be 583333 Iraqi Dinar for the entire course) thats rather than other medications and for one family member. Local production prices are high in comparison to imported ones, as in (levofloxacin and Favipiravir). Many medications had increased their prices after the pandemic due to demand, availability and exchange rate.

Conclusion:

The Iraqi government has to provide medications for the Iraqi people in public hospitals and clinics so that patients do not need to go to private ones. Medications prices have to be controlled uninformed by the government.(AU)

Conselho Nacional de Secretários de Saúde (CONASS)

Informação e Conhecimento para a Saúde

Formato de exportação: